News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

DNA double helix - computer visualisation
How the Human Genome Project shook the world of cancer research

15/02/21

Twenty years ago, a detailed draft and analysis of the human genome was completed. In this feature, Diana Cano Bordajandi looks at the lasting legacy of the Human Genome Project.
Johann de Bono and Mateus Crespo Prostate cancer cells 547x410
Men with early stage testicular cancer could avoid potentially harmful monitoring scans

12/02/21

Men who have had treatment for early stage testicular cancer could benefit from fewer monitoring scans, freeing them from some of the harmful radiation that comes from computerized tomography (CT) imaging, according to results presented at GU ASCO conference.
radiology article
Common antiseptic could be cheap and easy way to improve cancer radiotherapy around the world

03/02/21

A simple injection of a common antiseptic could boost the cancer-killing effect of radiotherapy for breast cancer and other cancers, an early clinical trial has shown.
Radiotherapy machine at The Royal Marsden Hospital
Shorter radiotherapy course reduces risk of bladder cancer returning

01/02/21

Giving people with bladder cancer fewer but larger doses of radiation reduces the risk of their disease returning and should be adopted as the new standard of care, a new study shows.
Breast cancer cell
Existing breast cancer drug offers new targeted treatment for triple negative breast cancer

28/01/21

An already approved breast cancer drug could bring hope to thousands of UK women who have an aggressive form of breast cancer, new research has found.
Prostate cancer cell 547x410
Promising new treatment strategy for men with drug-resistant prostate cancer

12/01/21

A new experimental drug could offer a promising approach to treating men with advanced prostate cancer which does not respond to existing treatments, or develops resistance to them, researchers report.
DNA double helix - computer visualisation
Study sheds light on genetic basis of Black men’s higher prostate cancer risk

04/01/21

Black men are more likely than their White or Asian counterparts to have a range of genetic changes that increase their risk of developing prostate cancer, a major new study reports.
BRCA2 team group photo
The BRCA2 team: Researchers behind the breast cancer gene discovery

21/12/20

25 years ago, ICR researchers made a historic discovery. Juanita Bawagan recounts some of their stories.
Split image of Sir Richard Doll building in Sutton and Imperial College building in South Kensington 547x410
New collaboration to advance cancer prevention research and strategies

18/12/20

A new unit focusing on cancer prevention research and strategies has launched at The Institute of Cancer Research, London, and Imperial College London.
RNA Polymerase III
New 3D structure could be ‘a treasure map’ guiding search for new treatments

17/12/20

Scientists have created a three-dimensional map of a complex of molecules that plays a fundamental role in life – and which when it goes wrong is linked to increased sensitivity to viral infections and neurodegenerative diseases.
Woman playing the violin
Symphony finished to mark new era for cancer drug discovery

10/12/20

The ICR and Royal Philharmonic Orchestra complete the ‘unfinished symphony’ – to mark the opening of a revolutionary new research centre and a new era for cancer treatment.
Oral squamous cancer cell (white) being attacked by two cytotoxic T cells (red)
Researchers target thyroid cancer with triple threat drug combination

09/12/20

Combining a genetically targeted drug, a cancer-bursting virus and a drug that removes the immune system’s brake pedal can tackle thyroid cancer with newfound gusto, research has found.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.